Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin. 2015;24(3):379–96. https://doi.org/10.1016/j.soc.2015.03.001.
Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, ... Clark C. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. The Lancet. 2019;393(10166), 51–60. https://doi.org/10.1016/S0140-6736(18)32752-1
Deuning-Smit E, Custers JA, Miroševič Š, Takes RP, Jansen F, Langendijk JA, Terhaard CH, Baatenburg de Jong RJ, Leemans CR, Smit JH, Kwakkenbos L, Verdonck-de Leeuw IM, Prins JB. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: course, trajectories, and associated factors. Head Neck. 2022;44(4):914–25. https://doi.org/10.1002/hed.26985.
Article PubMed PubMed Central Google Scholar
Mirosevic S, Thewes B, van Herpen C, Kaanders J, Merkx T, Humphris G, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Terhaard CHJ, Verdonck-de Leeuw IM, Takes R, Prins J. Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer. Head Neck. 2019;41(9):3187–320. https://doi.org/10.1002/hed.25812.
Article PubMed PubMed Central Google Scholar
Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, Dinkel A, Butow P. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–8. https://doi.org/10.1007/s00520-016-3272-5.
Giuliani M, McQuestion M, Jones J, Papadakos J, Le LW, Alkazaz N, Cheng T, Waldron J, Catton P, Ringash J. Prevalence and nature of survivorship needs in patients with head and neck cancer. Head Neck. 2016;38(7):1097–103. https://doi.org/10.1002/hed.24411.
Henry M, Habib LA, Morrison M, Yang JW, Li XJ, Lin S, Zeitouni A, Payne R, MacDonalds C, Mlynarek A, Kost K, Black M, Hier M. Head and neck cancer patients want us to support them psychologically in the posttreatment period: survey results. Palliat Support Care. 2014;12(6):481–93. https://doi.org/10.1017/S1478951513000771.
Wells M, Cunningham M, Lang H, Swartzman S, Philp J, Taylor L, Thomson J. Distress, concerns and unmet needs in survivors of head and neck cancer: a cross-sectional survey. Eur J Cancer Care. 2015;24(5):748–60. https://doi.org/10.1111/ecc.12370.
Herschbach P, Dinkel A. Fear of progression. Psychooncology. 2013;197:11–29. https://doi.org/10.1007/978-3-642-40187-9_2.
Lee-Jones C, Humphris G, Dixon R, Bebbington Hatcher M. Fear of cancer recurrence — a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95–105. https://doi.org/10.1002/(SICI)1099-1611(199706)6:2%3c95::AID-PON250%3e3.0.CO;2-B.
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Survivorship: Res Pract. 2013;7(3):300–22. https://doi.org/10.1007/s11764-013-0272-z.
Leclair CS, Lebel S, Westmaas JL. The relationship between fear of cancer recurrence and health behaviors: a nationwide longitudinal study of cancer survivors. Health Psychol. 2019;38(7):596–605. https://doi.org/10.1037/hea0000754.
Williams JT, Pearce A, Smith AB. A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology. 2021;30(8):1185–95. https://doi.org/10.1002/pon.5673.
van Beek FE, Jansen F, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Smit JH, ... Verdonck-de Leeuw IM. Psychological problems among head and neck cancer patients in relation to utilization of healthcare and informal care and costs in the first two years after diagnosis. Current Oncology. 2022;29(5), 3200–3214. https://doi.org/10.3390/curroncol29050260
Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, Prins J, Sharpe L, Smith AB, Thewes B, Lebel S. Identifying the key characteristics of clinical fear of cancer recurrence: an international delphi study. Psychooncology. 2020;29(2):430–6. https://doi.org/10.1002/pon.5283.
Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, Mahey C, Ozakinci G, Prins JB, Sharpe L, Smith AB, Thewes B, Simard S, Zachariae R. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899–915. https://doi.org/10.1200/jco.19.00572.
Article PubMed PubMed Central Google Scholar
Van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35(19):2173–83. https://doi.org/10.1200/jco.2016.70.5301.
Rogers SN, Monssen C, Humphris GM, Lowe D, Kanatas A. Which head and neck cancer patients are most at risk of high levels of fear of cancer recurrence. Front Psychol. 2021;12:671366. https://doi.org/10.3389/fpsyg.2021.671366.
Article PubMed PubMed Central Google Scholar
Chen LYU, Yan XU, Meng ZHOU, Lilu TIAN. Study on fear of recurrence and its influencing factors in patients with primary breast cancer. Tianjin J Nurs. 2021;29(3):259. https://doi.org/10.3969/j.issn.1006-9143.2021.03.002.
Ng DW, Kwong A, Suen D, Chan M, Or A, Ng SS, Foo CC, Fielding BF, Lam WW. Fear of cancer recurrence among Chinese cancer survivors: prevalence and associations with metacognition and neuroticism. Psychooncology. 2019;28(6):1243–51. https://doi.org/10.1002/pon.5073.
Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2022;45(5):406–15. https://doi.org/10.1097/NCC.0000000000001020.
Llewellyn CD, Weinman J, McGurk M, Humphris G. Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res. 2008;65(6):525–32. https://doi.org/10.1016/j.jpsychores.2008.03.014.
Ghazali N, Cadwallader E, Lowe D, Humphris G, Ozakinci G, Rogers SN. Fear of recurrence among head and neck cancer survivors: longitudinal trends. Psychooncology. 2012;22(4):807–13. https://doi.org/10.1002/pon.3069.
Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11. https://doi.org/10.1002/pon.3022.
Meissner VH, Olze L, Schiele S, Ankerst DP, Jahnen M, Gschwend JE, Herkommer K, Dinkel A. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: a longitudinal study. Cancer. 2021;127(22):4287–95. https://doi.org/10.1002/cncr.33836.
Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res. 2013;74(4):354–60. https://doi.org/10.1016/j.jpsychores.2012.12.013.
Deuning-Smit E, Kolsteren EE, Kwakkenbos L, Custers JA, Hermens RP, Prins JB. Barriers and facilitators for implementation of the SWORD evidence-based psychological intervention for fear of cancer recurrence in three different healthcare settings. J Cancer Surviv. 2022;17(4):1057–71. https://doi.org/10.1007/s11764-022-01285-x.
Article PubMed PubMed Central Google Scholar
Prins JB, Deuning-Smit E, Custers JA. Interventions addressing fear of cancer recurrence: challenges and future perspectives. Curr Opin Oncol. 2022;34(4):279–84. https://doi.org/10.1097/CCO.0000000000000837.
Custers JA, Kwakkenbos L, Van de Wal M, Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the cancer worry scale. Psychooncology. 2018;27(11):2609–15. https://doi.org/10.1002/pon.4782.
Paleri V, Wight RG. Applicability of the adult comorbidity evaluation–27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol. 2002;116(3):200–5. https://doi.org/10.1258/0022215021910528.
Braeken AP, Kempen GI, Watson M, Houben RM, Gils FC, Lechner L. Psychometric properties of the Dutch version of the mental adjustment to cancer scale in Dutch cancer patients. Psychooncology. 2009;19(7):742–9. https://doi.org/10.1002/pon.1628.
Comments (0)